This #holiday season, we’re honored to partner with Letters Against Isolation to spread joy to seniors who may be feeling lonely. Senior loneliness is a significant issue, impacting not only mental health but physical health as well. With many seniors living in assisted living facilities and care homes, this initiative offers a simple yet powerful way to make a difference. Our team came together to write heartfelt, handwritten letters filled with messages of love, hope and holiday cheer. #GiveBack
Kelonia Therapeutics
Biotechnology
Boston, Massachusetts 3,927 followers
Revolutionizing in vivo gene delivery to usher in a new era of genetic medicines.
About us
Kelonia is pioneering a new wave of genetic medicines using its next generation gene delivery platform. The company’s simple and elegant cutting-edge in vivo gene delivery technology uses a few potent lentiviral vector-like particles to precisely and efficiently deliver in vivo genetic cargo to the desired target tissue, and only that tissue, every time. With an initial focus on developing transformational therapies for solid tumors and hematologic cancers, Kelonia is building a pipeline of genetic medicines for a wide range of diseases, with the bold goal of bringing genetic medicines to every patient in need.
- Website
-
http://www.keloniatx.com/
External link for Kelonia Therapeutics
- Industry
- Biotechnology
- Company size
- 11-50 employees
- Headquarters
- Boston, Massachusetts
- Type
- Privately Held
Locations
-
Primary
Boston, Massachusetts, US
Employees at Kelonia Therapeutics
-
Mathai Mammen, M.D., Ph.D.
Chairman/CEO, Parabilis Medicines; Former EVP R&D, Johnson & Johnson
-
Shannon Grande Contrastano
VP, Preclinical Research at Kelonia Therapeutics
-
Russell M.
Director of Discovery Research
-
Stephen Cassidy
Associate Director, Lab Facilities & Operations at Kelonia Therapeutics
Updates
-
#ICYMI: Our CEO, Kevin Friedman, was recently featured in an article by pharmaphorum exploring the groundbreaking potential of #invivo cell therapies to ease the treatment burden and expand the accessibility of #geneticmedicines. Learn more about the growing field and read the full article here: https://lnkd.in/eACKYWxn.
-
We’re still buzzing from an unforgettable day at TD Garden with Special Olympics Massachusetts! It was an honor to take to the Boston Celtics home court alongside our partner athletes as one of the top fundraising teams for Bio-Ball, uniting for a cause that embodies #inclusion and #teamwork. Huge thanks to the organizers and athletes who made this event so special!
-
We aim to develop transformative #GeneticMedicines leveraging our next-generation gene delivery system to develop a safer, more effective, and more accessible treatment option for patients with #cancer, without the need for chemotherapy. Learn how our revolutionary iGPS® technology can make #CARTcell therapies available to patients when and where they need them: https://lnkd.in/gYv4s83T
-
After our move to our new office earlier this year, we were eager to kick off our first holiday season in Dorchester by partnering with a local organization to give back to those in need within our new neighborhood. Thanks to our team and their generous donations, we were able to partner with Pilgrim Congregational Church’s Food Bank to donate Thanksgiving Dinner Baskets to 10 local families and an additional $1400 in grocery store gift cards to support other families in need. We’re grateful to be part of such a vibrant neighborhood, and look forward to continuing to make a positive impact in the future! #TeamKelonia
-
Members of our team had a great time at the BostInno Fire Awards Reception last night! We were honored to be recognized as a top #biotech startup alongside other outstanding companies igniting innovation in our community. Thank you, BostInno, for celebrating our efforts; we are proud to have our roots in #Boston! #InnoFire
-
Our Process Development team is growing! We are excited to add a skilled Downstream PD Senior Scientist to our team who will play a pivotal role in viral vector purification strategies. Apply today if this sounds like the right fit for you: https://lnkd.in/eAX27FGX. #TeamKelonia #Hiring #BiotechJobs
-
In vivo #CARTcell therapies represent the next frontier in genetic medicine - improving upon the speed, safety, cost and accessibility of ex vivo therapies. Our CEO, Kevin Friedman, recently sat down with pharmaphorum's Jonah Comstock to discuss our work and what's next for the growing #invivo CAR-T field: https://lnkd.in/eACKYWxn.
-
To put it plainly, our goal at Kelonia is to change what’s possible for genetic medicines. We are building a people-first company with the capability, experience and commitment to bring transformative medicines to every patient in need. We are grateful for our extraordinary team – one that values both skill and care. Learn more about us: https://keloniatx.com/
-
#CARTcell therapies genetically engineer a patient's own #Tcells to recognize specific antigens present on #cancer cells. Learn more about our unique approach to developing #invivo CAR-T therapies that would eliminate complex and costly manufacturing processes and make CAR-T more accessible to a broader population of patients: https://lnkd.in/gYv4s83T.